Literature DB >> 20563871

An outstanding non-transplant surgical intervention in progressive familial intrahepatic cholestasis: partial internal biliary diversion.

F Gün1, B Erginel, O Durmaz, S Sökücü, T Salman, A Celik.   

Abstract

AIM: Progressive familial intrahepatic cholestasis (PFIC) is a hereditary disease with severe cholestasis progressing to cirrhosis and chronic renal failure usually during the first decade. An alternative approach is partial diversion of bile. The aim of this study is to describe four patients with PFIC who underwent partial internal biliary diversion (PIBD).
METHODS: Review of three patients, their clinical, laboratory and histologic workups to evaluate the short-term effects of PFIC, a 1-year follow-up. For PIBD, a conduit is performed between the terminolateral side of the gall bladder and distal colon using a segment of jejunum, to divert the biliary flow from the enterohepatic cycle without any external stoma.
RESULTS: All four patients were presented with jaundice, pruritus, hepatomegaly, sleep disturbance. They fulfilled the criteria for PFIC. The surgery was uneventful. At follow-up, biochemical parameters improved significantly, growth was regained, relief in pruritus, sleeping pattern was normalized.
CONCLUSIONS: Partial internal biliary diversion had a dramatic effect on cholestasis, growth, sleeping and biochemical parameters. It also avoids the disadvantages of a permanent stoma. We believe that it is one of the best surgical procedures ever described for PFIC. Since long-term results of partial external biliary diversion on liver histopathology are successful, we hope that our long-term results will also be similar.

Entities:  

Mesh:

Year:  2010        PMID: 20563871     DOI: 10.1007/s00383-010-2638-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  13 in total

1.  Biliary diversion by use of the appendix (cholecystoappendicostomy) in progressive familial intrahepatic cholestasis.

Authors:  W Rebhandl; F X Felberbauer; J Turnbull; K Paya; U Barcik; W D Huber; P F Whitington; E Horcher
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-02       Impact factor: 2.839

2.  Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.

Authors:  M Melter; B Rodeck; R Kardorff; P F Hoyer; C Petersen; A Ballauff; J Brodehl
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

3.  Clinical and biochemical findings in progressive familial intrahepatic cholestasis.

Authors:  P F Whitington; D K Freese; E M Alonso; S J Schwarzenberg; H L Sharp
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-02       Impact factor: 2.839

Review 4.  Progressive familial intrahepatic cholestasis type 1.

Authors:  Coen C Paulusma; Ronald P J Oude Elferink; Peter L M Jansen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

5.  Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus.

Authors:  C M Hollands; F J Rivera-Pedrogo; R Gonzalez-Vallina; O Loret-de-Mola; M Nahmad; C A Burnweit
Journal:  J Pediatr Surg       Date:  1998-02       Impact factor: 2.545

6.  Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.

Authors:  H Ismail; P Kaliciński; M Markiewicz; I Jankowska; J Pawłowska; P Kluge; E Eliadou; A Kamiński; M Szymczak; T Drewniak; Y Revillon
Journal:  Pediatr Transplant       Date:  1999-08

7.  Laparoscopic partial external biliary diversion procedure in progressive familial intrahepatic cholestasis: a new approach.

Authors:  M L Metzelder; M Bottländer; M Melter; C Petersen; B M Ure
Journal:  Surg Endosc       Date:  2005-12       Impact factor: 4.584

Review 8.  Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases.

Authors:  Saniye Ekinci; Ibrahim Karnak; Figen Gürakan; Aysel Yüce; Mehmet Emin Senocak; F Cahit Tanyel; Nebil Büyükpamukçu
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

9.  Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis.

Authors:  P F Whitington; G L Whitington
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

10.  Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.

Authors:  P J Kaliciński; H Ismail; I Jankowska; A Kamiński; J Pawłowska; T Drewniak; M Markiewicz; M Szymczak
Journal:  Eur J Pediatr Surg       Date:  2003-10       Impact factor: 2.191

View more
  10 in total

1.  Partial internal biliary diversion for patients with progressive familial intrahepatic cholestasis type 1.

Authors:  Kyoko Mochizuki; Masayuki Obatake; Mitsuhisa Takatsuki; Akiko Nakatomi; Tomayoshi Hayashi; Sadayuki Okudaira; Susumu Eguchi
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

Review 2.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

3.  Long-term outcome following cholecystocolostomy in 41 patients with progressive familial intrahepatic cholestasis.

Authors:  Qianqing Li; Clara Chong; Rui Sun; Tong Yin; Ting Huang; Mei Diao; Long Li
Journal:  Pediatr Surg Int       Date:  2021-03-02       Impact factor: 1.827

Review 4.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

5.  Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.

Authors:  Kasper S Wang; Greg Tiao; Lee M Bass; Paula M Hertel; Douglas Mogul; Nanda Kerkar; Matthew Clifton; Colleen Azen; Laura Bull; Philip Rosenthal; Dylan Stewart; Riccardo Superina; Ronen Arnon; Molly Bozic; Mary L Brandt; Patrick A Dillon; Annie Fecteau; Kishore Iyer; Binita Kamath; Saul Karpen; Frederick Karrer; Kathleen M Loomes; Cara Mack; Peter Mattei; Alexander Miethke; Kyle Soltys; Yumirle P Turmelle; Karen West; Jessica Zagory; Cat Goodhue; Benjamin L Shneider
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

6.  Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients.

Authors:  Hamid Reza Foroutan; Ali Bahador; Sultan Mohsin Ghanim; Seyed Mohsen Dehghani; Mohammad Hossein Anbardar; Mohammad Reza Fattahi; Mehdi Forooghi; Omidreza Azh; Ali Tadayon; Alireza Sherafat; Amir Arsalan Yaghoobi; Mohammad Ali Ashraf
Journal:  Pediatr Surg Int       Date:  2020-03-23       Impact factor: 1.827

Review 7.  Current and future therapies for inherited cholestatic liver diseases.

Authors:  Wendy L van der Woerd; Roderick Hj Houwen; Stan Fj van de Graaf
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

8.  Expanding etiology of progressive familial intrahepatic cholestasis.

Authors:  Sarah Af Henkel; Judy H Squires; Mary Ayers; Armando Ganoza; Patrick Mckiernan; James E Squires
Journal:  World J Hepatol       Date:  2019-05-27

9.  Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients.

Authors:  Teng Liu; Ren-Xue Wang; Jun Han; Yi-Ling Qiu; Christoph H Borchers; Victor Ling; Jian-She Wang
Journal:  Ann Transl Med       Date:  2020-03

10.  Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.

Authors:  Deng Xiang; Jiannan He; Hongmei Wang; Fangfang Xiong; Hao Cheng; Junhua Ai; Renfeng Shan; Renhua Wan; Lunli Zhang; Jun Shi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.